Tarsons Products Limited
Tarsons Products Limited Fundamental Analysis
Tarsons Products Limited (TARSONS.BO) shows weak financial fundamentals with a PE ratio of 47.50, profit margin of 4.91%, and ROE of 3.25%. The company generates $4.1B in annual revenue with strong year-over-year growth of 32.40%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 38.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze TARSONS.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakTARSONS.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateTARSONS.BO shows balanced valuation metrics.
Growth Score
ModerateTARSONS.BO shows steady but slowing expansion.
Financial Health Score
ExcellentTARSONS.BO maintains a strong and stable balance sheet.
Profitability Score
WeakTARSONS.BO struggles to sustain strong margins.
Key Financial Metrics
Is TARSONS.BO Expensive or Cheap?
P/E Ratio
TARSONS.BO trades at 47.50 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, TARSONS.BO's PEG of -45.96 indicates potential undervaluation.
Price to Book
The market values Tarsons Products Limited at 1.54 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 4.24 times EBITDA. This is generally considered low.
How Well Does TARSONS.BO Make Money?
Net Profit Margin
For every $100 in sales, Tarsons Products Limited keeps $4.91 as profit after all expenses.
Operating Margin
Core operations generate 8.01 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.25 in profit for every $100 of shareholder equity.
ROA
Tarsons Products Limited generates $1.75 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Tarsons Products Limited produces operating cash flow of $444.51M, showing steady but balanced cash generation.
Free Cash Flow
Tarsons Products Limited generates weak or negative free cash flow of $-267.75M, restricting financial flexibility.
FCF Per Share
Each share generates $-5.03 in free cash annually.
FCF Yield
TARSONS.BO converts -2.77% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
47.50
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-45.96
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.54
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.33
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.63
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.03
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.03
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How TARSONS.BO Stacks Against Its Sector Peers
| Metric | TARSONS.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 47.50 | 28.45 | Worse (Expensive) |
| ROE | 3.25% | 763.00% | Weak |
| Net Margin | 4.91% | -45265.00% (disorted) | Weak |
| Debt/Equity | 0.63 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.03 | 2795.60 | Neutral |
| ROA | 1.75% | -16588.00% (disorted) | Weak |
TARSONS.BO outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Tarsons Products Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
115.39%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-29.46%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
44.51%
Industry Style: Defensive, Growth, Innovation
High Growth